The Medical News

1. Identifying the ages when Alzheimer’s biomarkers sharply change

   New research identifies critical ages for Alzheimer's biomarkers, enhancing screening strategies and understanding neurodegeneration across the aging spectrum.

2. AI scribes save clinicians time but fail to reduce overtime work

   While AI scribes reduce documentation time, their effect on after-hours work is minimal, highlighting the need for further studies on clinician productivity.

3. How fast your face ages may predict cancer survival outcomes

   The study links facial aging rates to cancer outcomes, suggesting a new prognostic tool that could personalize treatment and enhance patient survival.

4. Food timing may shape how T cells respond to infection and therapy

   Short-term nutritional state can reshape T cell metabolism, with post-meal lipid metabolism enhancing T cell metabolic capacity, cytokine production, and persistence after activation. The study identifies triglyceride-rich chylomicrons as key drivers of this effect, suggesting nutritional timing may matter for immune monitoring, vaccination research, and cell-therapy manufacturing.

5. Five-target drug beats GLP-1/GIP therapy in obese diabetic mice

   A Nature study reports a single-molecule GLP-1–GIP–lanifibranor quintuple agonist that targets incretin receptor-expressing cells while activating PPARα/γ/δ pathways. In obese and insulin-resistant mice, the compound reduced body weight, food intake, and hyperglycaemia more effectively than semaglutide or GLP-1R–GIPR co-agonism, while remaining a preclinical finding.

6. New genetic risk report reveals hidden heart disease risk before symptoms appear

   Researchers developed and externally validated integrated polygenic risk scores for eight cardiovascular conditions using large U.S.-based biobank data. The clinically orderable report may help identify inherited cardiovascular risk that traditional clinical markers can miss, although broader prospective validation is still needed.

7. AgentClinic puts medical AI through a more realistic diagnostic test

   AgentClinic is a multimodal benchmark that tests clinical AI agents in simulated, dialogue-driven diagnostic settings rather than static medical question-answer formats. The study found that model performance varied sharply by tool use, language, bias, image handling, and patient-agent interactions, highlighting the need for more realistic AI evaluation before clinical deployment.

8. New screening tool predicts health risks for people living with obesity

   A simple tool, developed by researchers at Queen Mary University of London and the Berlin Institute of Health at Charité, could help identify which people living with obesity or overweight are most likely to develop serious obesity-related conditions such as type 2 diabetes and heart disease.